Clinical Trial 21885

• Overview

  Study Title:

  Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

  Summary:

  The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.

  Objective:

  Primary Aim: Evaluate the efficacy of MAPS+ and ST in facilitating long-term smoking abstinence. Secondary Aim: Compare the magnitude of the mediated effects via common mechanisms (i.e., motivation, agency, and stress/negative affect) on smoking abstinence between the MAPS+ and ST treatment groups.

• Inclusion Criteria

  Inclusion Criteria:
  • At least 100 cigarettes or more smoked in participants lifetime
  • Speaks English
  • Currently smoke 1 cigarette or more in the past 30 days
  • History of cervical cancer or high-grade cervical dysplasia
  • Has a working smartphone
  • Has a valid home address
  • Reside in Florida at the time of study enrollment

• Exclusion Criteria

  Exclusion Criteria:
  • Receiving behavioral or pharmacological tobacco treatment
  • Household member enrolled in this study

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.